Chair of EMA’s committee for orphan medicines receives award for outstanding patient engagement

January 15, 2018 – Bruno Sepodes, Chair of the European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products (COMP), has received the EURORDIS European Rare Disease Leadership Award as recognition of his commitment to involve patient advocates in all discussions and decisions related to orphan medicines. The EURORDIS Black Pearl Awards acknowledge the outstanding achievements and exceptional work of people making a difference for … (leggi tutto)